PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
02-May-2022 IGEA Pharma N.V.: IGEA to get SIX approval to delay the 2021 annual report disclosure IGEA Pharma N.V.
30-Apr-2022 Vita 34 AG: Special items reflected in significant decline in earnings despite operational success in fiscal 2021 Vita 34 AG
29-Apr-2022 Xlife Sciences publishes annual results 2021 and outlook 2022 Xlife Sciences AG
29-Apr-2022 Vita 34 publishes revenue and earnings forecast for the 2022 financial year Vita 34 AG
29-Apr-2022 CHEPLAPHARM CONTINUES PROFITABLE GROWTH TRACK IN 2021 AS WELL Cheplapharm AG
29-Apr-2022 Moderna Files to Expand Conditional Marketing Authorization for Its COVID-19 Vaccine to Include Children Six Months to Under Six Years in The European Union Moderna, Inc.
29-Apr-2022 PureTech Founded Entity Gelesis Announces its Proprietary Superabsorbent Hydrogel Induced Beneficial Changes to the Gut Microbiota and Expanded Akkermansia, a Bacterial Species Associated with Gut Health and Weight Loss, in New Study PureTech
29-Apr-2022 Immutep quarterly activities report and Appendix 4C Immutep Limited
29-Apr-2022 Bone Therapeutics announces 2021 full year results Bone Therapeutics
29-Apr-2022 Envirotainer is driving the shift to a more sustainable pharmaceutical cold chain Envirotainer
29-Apr-2022 Weekly Life Science News Round Up: 25th – 29th April PharmiWeb.Jobs
29-Apr-2022 Continued strategic progress and updated full year guidance following Custopharm acquisition Hikma Pharmaceuticals PLC
29-Apr-2022 Santhera will Publish its 2021 Annual Report by June 3, 2022, and Hold its Annual General Meeting on June 29, 2022 Santhera
29-Apr-2022 New number of shares and votes in Moberg Pharma AB (publ) Moberg Pharma AB
29-Apr-2022 Janssen Submits Marketing Authorisation Application to EMA Seeking Approval of Niraparib and Abiraterone Acetate Dual Action Tablet Plus Prednisone for the Treatment of Patients with HRR Gene-Mutated Metastatic Castration Resistant Prostate Cancer Janssen Pharmaceutical Companies of Johnson & Johnson
29-Apr-2022 ESG Report 2021: SYNLAB defines high-impact areas to drive its ambitious environmental, social and governance agenda SYNLAB AG
28-Apr-2022 Invitation to MorphoSys' First Quarter 2022 Financial Results Conference Call on May 5, 2022 MorphoSys AG
28-Apr-2022 Zur Rose Group AG: Shareholders approve all proposals Zur Rose Group AG
28-Apr-2022 Abivax publishes Universal Registration Document 2022 'Document d'Enregistrement Universel' ABIVAX
28-Apr-2022 AEVIS VICTORIA SA - Ordinary General Meeting of Shareholders: all proposals approved AEVIS VICTORIA SA